nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP3A4—Temozolomide—brain cancer	0.136	0.39	CbGbCtD
Bezafibrate—CYP3A4—Lomustine—brain cancer	0.116	0.332	CbGbCtD
Bezafibrate—CYP2C8—Etoposide—brain cancer	0.0689	0.198	CbGbCtD
Bezafibrate—CYP3A4—Etoposide—brain cancer	0.028	0.0802	CbGbCtD
Bezafibrate—PPARD—Pyruvate metabolism—BSG—brain cancer	0.0108	0.0391	CbGpPWpGaD
Bezafibrate—PPARG—Teniposide—Etoposide—brain cancer	0.0102	1	CbGdCrCtD
Bezafibrate—PPARA—blood vessel—brain cancer	0.0102	0.0977	CbGeAlD
Bezafibrate—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00964	0.0348	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—TSC22D1—brain cancer	0.00952	0.0344	CbGpPWpGaD
Bezafibrate—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00843	0.0304	CbGpPWpGaD
Bezafibrate—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00826	0.0298	CbGpPWpGaD
Bezafibrate—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00757	0.0274	CbGpPWpGaD
Bezafibrate—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00752	0.0272	CbGpPWpGaD
Bezafibrate—PPARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00734	0.0265	CbGpPWpGaD
Bezafibrate—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00689	0.0249	CbGpPWpGaD
Bezafibrate—PPARD—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.00655	0.0236	CbGpPWpGaD
Bezafibrate—Fenofibrate—CYP2C9—brain cancer	0.00623	0.401	CrCbGaD
Bezafibrate—PPARG—endothelium—brain cancer	0.00607	0.0583	CbGeAlD
Bezafibrate—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00587	0.0212	CbGpPWpGaD
Bezafibrate—Transaminases increased—Carmustine—brain cancer	0.00585	0.0239	CcSEcCtD
Bezafibrate—PPARD—telencephalon—brain cancer	0.00579	0.0556	CbGeAlD
Bezafibrate—PPARG—blood vessel—brain cancer	0.00559	0.0537	CbGeAlD
Bezafibrate—HMGCR—SREBF and miR33 in cholesterol and lipid homeostasis—SIRT1—brain cancer	0.00546	0.0197	CbGpPWpGaD
Bezafibrate—Pancytopenia—Lomustine—brain cancer	0.00534	0.0218	CcSEcCtD
Bezafibrate—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00526	0.019	CbGpPWpGaD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—DLL1—brain cancer	0.00514	0.0186	CbGpPWpGaD
Bezafibrate—PPARA—SREBF and miR33 in cholesterol and lipid homeostasis—SIRT1—brain cancer	0.005	0.018	CbGpPWpGaD
Bezafibrate—Moclobemide—CYP2C9—brain cancer	0.00484	0.312	CrCbGaD
Bezafibrate—HMGCR—AMPK Signaling—STRADA—brain cancer	0.00481	0.0174	CbGpPWpGaD
Bezafibrate—Photosensitivity—Procarbazine—brain cancer	0.00471	0.0192	CcSEcCtD
Bezafibrate—Vascular purpura—Procarbazine—brain cancer	0.00462	0.0189	CcSEcCtD
Bezafibrate—Cholestasis—Temozolomide—brain cancer	0.00453	0.0185	CcSEcCtD
Bezafibrate—Purpura—Procarbazine—brain cancer	0.00429	0.0175	CcSEcCtD
Bezafibrate—PPARD—midbrain—brain cancer	0.00416	0.0399	CbGeAlD
Bezafibrate—PPARD—Nuclear Receptors—ESR2—brain cancer	0.00408	0.0147	CbGpPWpGaD
Bezafibrate—Alopecia—Lomustine—brain cancer	0.00398	0.0163	CcSEcCtD
Bezafibrate—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00397	0.0143	CbGpPWpGaD
Bezafibrate—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00382	0.0138	CbGpPWpGaD
Bezafibrate—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00372	0.0152	CcSEcCtD
Bezafibrate—PPARD—endocrine gland—brain cancer	0.00365	0.0351	CbGeAlD
Bezafibrate—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.00364	0.0131	CbGpPWpGaD
Bezafibrate—Infection—Carboplatin—brain cancer	0.00363	0.0149	CcSEcCtD
Bezafibrate—PPARA—Orphan transporters—S100A10—brain cancer	0.00362	0.0131	CbGpPWpGaD
Bezafibrate—PPARD—head—brain cancer	0.00361	0.0346	CbGeAlD
Bezafibrate—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.0035	0.0126	CbGpPWpGaD
Bezafibrate—Renal failure acute—Hydroxyurea—brain cancer	0.00346	0.0142	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Temozolomide—brain cancer	0.00344	0.0141	CcSEcCtD
Bezafibrate—Pancytopenia—Procarbazine—brain cancer	0.00339	0.0139	CcSEcCtD
Bezafibrate—PPARD—central nervous system—brain cancer	0.00329	0.0316	CbGeAlD
Bezafibrate—HMGCR—telencephalon—brain cancer	0.00328	0.0315	CbGeAlD
Bezafibrate—Photosensitivity reaction—Procarbazine—brain cancer	0.00326	0.0133	CcSEcCtD
Bezafibrate—PPARD—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00322	0.0116	CbGpPWpGaD
Bezafibrate—PPARD—cerebellum—brain cancer	0.00322	0.0309	CbGeAlD
Bezafibrate—Infection—Lomustine—brain cancer	0.00318	0.013	CcSEcCtD
Bezafibrate—Thrombocytopenia—Lomustine—brain cancer	0.00313	0.0128	CcSEcCtD
Bezafibrate—Pain—Carboplatin—brain cancer	0.00313	0.0128	CcSEcCtD
Bezafibrate—PPARA—endocrine gland—brain cancer	0.00311	0.0299	CbGeAlD
Bezafibrate—PPARA—Nuclear Receptors—ESR2—brain cancer	0.00311	0.0112	CbGpPWpGaD
Bezafibrate—PPARA—head—brain cancer	0.00307	0.0295	CbGeAlD
Bezafibrate—Blood creatinine increased—Hydroxyurea—brain cancer	0.003	0.0123	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00287	0.0117	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—SMARCB1—brain cancer	0.00283	0.0102	CbGpPWpGaD
Bezafibrate—PPARA—central nervous system—brain cancer	0.0028	0.0269	CbGeAlD
Bezafibrate—Vascular purpura—Temozolomide—brain cancer	0.00279	0.0114	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Etoposide—brain cancer	0.00275	0.0113	CcSEcCtD
Bezafibrate—PPARA—cerebellum—brain cancer	0.00274	0.0263	CbGeAlD
Bezafibrate—HMGCR—gonad—brain cancer	0.00274	0.0263	CbGeAlD
Bezafibrate—HMGCR—pituitary gland—brain cancer	0.00267	0.0257	CbGeAlD
Bezafibrate—Pancytopenia—Hydroxyurea—brain cancer	0.00262	0.0107	CcSEcCtD
Bezafibrate—PPARD—brain—brain cancer	0.00261	0.0251	CbGeAlD
Bezafibrate—Purpura—Temozolomide—brain cancer	0.00259	0.0106	CcSEcCtD
Bezafibrate—HMGCR—medulla oblongata—brain cancer	0.00258	0.0248	CbGeAlD
Bezafibrate—PPARA—PPAR Alpha Pathway—CDK4—brain cancer	0.00256	0.00926	CbGpPWpGaD
Bezafibrate—PPARD—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.00254	0.00917	CbGpPWpGaD
Bezafibrate—Alopecia—Procarbazine—brain cancer	0.00253	0.0103	CcSEcCtD
Bezafibrate—PPARA—Estrogen Receptor Pathway—STAT3—brain cancer	0.00249	0.00898	CbGpPWpGaD
Bezafibrate—PPARA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00245	0.00887	CbGpPWpGaD
Bezafibrate—Liver function test abnormal—Carmustine—brain cancer	0.00239	0.00976	CcSEcCtD
Bezafibrate—HMGCR—midbrain—brain cancer	0.00236	0.0227	CbGeAlD
Bezafibrate—Indomethacin—CYP2C9—brain cancer	0.00233	0.15	CrCbGaD
Bezafibrate—HMGCR—spinal cord—brain cancer	0.0023	0.0221	CbGeAlD
Bezafibrate—Anaemia—Procarbazine—brain cancer	0.0023	0.0094	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.0023	0.0094	CcSEcCtD
Bezafibrate—Muscular weakness—Carmustine—brain cancer	0.00228	0.00932	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00225	0.0092	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00225	0.0092	CcSEcCtD
Bezafibrate—PPARG—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.00224	0.00808	CbGpPWpGaD
Bezafibrate—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.00223	0.00807	CbGpPWpGaD
Bezafibrate—PPARA—brain—brain cancer	0.00223	0.0214	CbGeAlD
Bezafibrate—PPARG—Nuclear Receptors—ESR2—brain cancer	0.00223	0.00804	CbGpPWpGaD
Bezafibrate—Alanine aminotransferase increased—Temozolomide—brain cancer	0.0022	0.00901	CcSEcCtD
Bezafibrate—Muscular weakness—Temozolomide—brain cancer	0.0022	0.00901	CcSEcCtD
Bezafibrate—Pancytopenia—Carmustine—brain cancer	0.00212	0.00868	CcSEcCtD
Bezafibrate—Myalgia—Procarbazine—brain cancer	0.00212	0.00866	CcSEcCtD
Bezafibrate—Glyburide—CYP2C9—brain cancer	0.00211	0.136	CrCbGaD
Bezafibrate—Bronchitis—Temozolomide—brain cancer	0.00208	0.00849	CcSEcCtD
Bezafibrate—HMGCR—endocrine gland—brain cancer	0.00207	0.0199	CbGeAlD
Bezafibrate—Pancytopenia—Temozolomide—brain cancer	0.00205	0.00838	CcSEcCtD
Bezafibrate—HMGCR—head—brain cancer	0.00205	0.0196	CbGeAlD
Bezafibrate—Infection—Procarbazine—brain cancer	0.00202	0.00825	CcSEcCtD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—APC—brain cancer	0.00201	0.00725	CbGpPWpGaD
Bezafibrate—Erectile dysfunction—Temozolomide—brain cancer	0.00199	0.00813	CcSEcCtD
Bezafibrate—Thrombocytopenia—Procarbazine—brain cancer	0.00199	0.00813	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—NTRK3—brain cancer	0.00199	0.00718	CbGpPWpGaD
Bezafibrate—SLCO1B1—endocrine gland—brain cancer	0.00198	0.0191	CbGeAlD
Bezafibrate—Photosensitivity reaction—Temozolomide—brain cancer	0.00197	0.00806	CcSEcCtD
Bezafibrate—Alopecia—Hydroxyurea—brain cancer	0.00196	0.00799	CcSEcCtD
Bezafibrate—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00195	0.00706	CbGpPWpGaD
Bezafibrate—Erythema—Hydroxyurea—brain cancer	0.00193	0.00787	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00191	0.0078	CcSEcCtD
Bezafibrate—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00191	0.00689	CbGpPWpGaD
Bezafibrate—Nausea—Lomustine—brain cancer	0.0019	0.00777	CcSEcCtD
Bezafibrate—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00188	0.00679	CbGpPWpGaD
Bezafibrate—HMGCR—central nervous system—brain cancer	0.00187	0.0179	CbGeAlD
Bezafibrate—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00185	0.00757	CcSEcCtD
Bezafibrate—Insomnia—Procarbazine—brain cancer	0.00184	0.00751	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—CDK6—brain cancer	0.00183	0.00661	CbGpPWpGaD
Bezafibrate—HMGCR—cerebellum—brain cancer	0.00182	0.0175	CbGeAlD
Bezafibrate—PPARD—Ectoderm Differentiation—SHH—brain cancer	0.00182	0.00656	CbGpPWpGaD
Bezafibrate—Cramp muscle—Etoposide—brain cancer	0.0018	0.00736	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Etoposide—brain cancer	0.0018	0.00736	CcSEcCtD
Bezafibrate—Anaemia—Hydroxyurea—brain cancer	0.00178	0.00728	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Etoposide—brain cancer	0.00176	0.00721	CcSEcCtD
Bezafibrate—PPARG—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.00176	0.00635	CbGpPWpGaD
Bezafibrate—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00175	0.00632	CbGpPWpGaD
Bezafibrate—Pain—Procarbazine—brain cancer	0.00174	0.0071	CcSEcCtD
Bezafibrate—Constipation—Procarbazine—brain cancer	0.00174	0.0071	CcSEcCtD
Bezafibrate—Pharyngitis—Temozolomide—brain cancer	0.00172	0.00701	CcSEcCtD
Bezafibrate—PPARG—endocrine gland—brain cancer	0.00171	0.0164	CbGeAlD
Bezafibrate—Urinary tract disorder—Temozolomide—brain cancer	0.00171	0.00698	CcSEcCtD
Bezafibrate—HMGCR—SREBP signalling—SIRT1—brain cancer	0.0017	0.00613	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—SKP2—brain cancer	0.0017	0.00612	CbGpPWpGaD
Bezafibrate—Urethral disorder—Temozolomide—brain cancer	0.00169	0.00693	CcSEcCtD
Bezafibrate—PPARG—head—brain cancer	0.00169	0.0162	CbGeAlD
Bezafibrate—Gastrointestinal pain—Procarbazine—brain cancer	0.00166	0.00679	CcSEcCtD
Bezafibrate—PPARA—PPAR Alpha Pathway—CCND1—brain cancer	0.00165	0.00598	CbGpPWpGaD
Bezafibrate—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00165	0.00595	CbGpPWpGaD
Bezafibrate—Pancytopenia—Etoposide—brain cancer	0.00164	0.00671	CcSEcCtD
Bezafibrate—Erythema multiforme—Temozolomide—brain cancer	0.00163	0.00668	CcSEcCtD
Bezafibrate—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00163	0.00588	CbGpPWpGaD
Bezafibrate—Urticaria—Procarbazine—brain cancer	0.00161	0.0066	CcSEcCtD
Bezafibrate—Abdominal pain—Procarbazine—brain cancer	0.00161	0.00656	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—DNMT1—brain cancer	0.00159	0.00576	CbGpPWpGaD
Bezafibrate—Alopecia—Carmustine—brain cancer	0.00158	0.00646	CcSEcCtD
Bezafibrate—Infection—Hydroxyurea—brain cancer	0.00156	0.00638	CcSEcCtD
Bezafibrate—Erythema—Carmustine—brain cancer	0.00156	0.00637	CcSEcCtD
Bezafibrate—PPARG—central nervous system—brain cancer	0.00154	0.0148	CbGeAlD
Bezafibrate—Thrombocytopenia—Hydroxyurea—brain cancer	0.00154	0.00629	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00153	0.00625	CcSEcCtD
Bezafibrate—Alopecia—Temozolomide—brain cancer	0.00153	0.00624	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Etoposide—brain cancer	0.00152	0.00621	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CDK6—brain cancer	0.00151	0.00546	CbGpPWpGaD
Bezafibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00151	0.00546	CbGpPWpGaD
Bezafibrate—Myocardial infarction—Etoposide—brain cancer	0.00151	0.00617	CcSEcCtD
Bezafibrate—Erythema—Temozolomide—brain cancer	0.0015	0.00615	CcSEcCtD
Bezafibrate—Hypersensitivity—Procarbazine—brain cancer	0.0015	0.00612	CcSEcCtD
Bezafibrate—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00149	0.00539	CbGpPWpGaD
Bezafibrate—HMGCR—brain—brain cancer	0.00148	0.0142	CbGeAlD
Bezafibrate—CYP2C8—pituitary gland—brain cancer	0.00146	0.014	CbGeAlD
Bezafibrate—Anaemia—Carmustine—brain cancer	0.00144	0.00588	CcSEcCtD
Bezafibrate—Pruritus—Procarbazine—brain cancer	0.00144	0.00588	CcSEcCtD
Bezafibrate—PPARG—Circadian rythm related genes—NTRK3—brain cancer	0.00142	0.00515	CbGpPWpGaD
Bezafibrate—Anaemia—Temozolomide—brain cancer	0.00139	0.00569	CcSEcCtD
Bezafibrate—Diarrhoea—Procarbazine—brain cancer	0.00139	0.00568	CcSEcCtD
Bezafibrate—Dyspepsia—Hydroxyurea—brain cancer	0.00138	0.00566	CcSEcCtD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—CCND1—brain cancer	0.00138	0.00497	CbGpPWpGaD
Bezafibrate—Urinary tract disorder—Etoposide—brain cancer	0.00137	0.00558	CcSEcCtD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—CTNNB1—brain cancer	0.00136	0.00492	CbGpPWpGaD
Bezafibrate—Urethral disorder—Etoposide—brain cancer	0.00136	0.00554	CcSEcCtD
Bezafibrate—Pain—Hydroxyurea—brain cancer	0.00134	0.0055	CcSEcCtD
Bezafibrate—Constipation—Hydroxyurea—brain cancer	0.00134	0.0055	CcSEcCtD
Bezafibrate—Dizziness—Procarbazine—brain cancer	0.00134	0.00549	CcSEcCtD
Bezafibrate—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00134	0.00484	CbGpPWpGaD
Bezafibrate—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00134	0.00483	CbGpPWpGaD
Bezafibrate—PPARA—PPAR Alpha Pathway—MYC—brain cancer	0.00133	0.00479	CbGpPWpGaD
Bezafibrate—Myalgia—Carmustine—brain cancer	0.00133	0.00542	CcSEcCtD
Bezafibrate—Erythema multiforme—Etoposide—brain cancer	0.00131	0.00535	CcSEcCtD
Bezafibrate—Myalgia—Temozolomide—brain cancer	0.00128	0.00524	CcSEcCtD
Bezafibrate—Rash—Procarbazine—brain cancer	0.00128	0.00524	CcSEcCtD
Bezafibrate—Dermatitis—Procarbazine—brain cancer	0.00128	0.00523	CcSEcCtD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00128	0.00462	CbGpPWpGaD
Bezafibrate—Headache—Procarbazine—brain cancer	0.00127	0.0052	CcSEcCtD
Bezafibrate—Infection—Carmustine—brain cancer	0.00126	0.00516	CcSEcCtD
Bezafibrate—Thrombocytopenia—Carmustine—brain cancer	0.00124	0.00509	CcSEcCtD
Bezafibrate—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00123	0.00443	CbGpPWpGaD
Bezafibrate—PPARG—brain—brain cancer	0.00122	0.0118	CbGeAlD
Bezafibrate—Alopecia—Etoposide—brain cancer	0.00122	0.005	CcSEcCtD
Bezafibrate—Infection—Temozolomide—brain cancer	0.00122	0.00499	CcSEcCtD
Bezafibrate—HMGCR—AMPK Signaling—PIK3CG—brain cancer	0.00121	0.00436	CbGpPWpGaD
Bezafibrate—Nausea—Procarbazine—brain cancer	0.00121	0.00493	CcSEcCtD
Bezafibrate—Thrombocytopenia—Temozolomide—brain cancer	0.0012	0.00492	CcSEcCtD
Bezafibrate—Hypersensitivity—Hydroxyurea—brain cancer	0.00116	0.00474	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Carmustine—brain cancer	0.00116	0.00473	CcSEcCtD
Bezafibrate—Muscle spasms—Etoposide—brain cancer	0.00116	0.00473	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—SIRT1—brain cancer	0.00115	0.00416	CbGpPWpGaD
Bezafibrate—Insomnia—Carmustine—brain cancer	0.00115	0.0047	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CCNE1—brain cancer	0.00114	0.00411	CbGpPWpGaD
Bezafibrate—CYP2C8—endocrine gland—brain cancer	0.00113	0.0108	CbGeAlD
Bezafibrate—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00112	0.00457	CcSEcCtD
Bezafibrate—Anaemia—Etoposide—brain cancer	0.00111	0.00455	CcSEcCtD
Bezafibrate—PPARG—SREBP signalling—SIRT1—brain cancer	0.00111	0.00402	CbGpPWpGaD
Bezafibrate—Insomnia—Temozolomide—brain cancer	0.00111	0.00454	CcSEcCtD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—MYC—brain cancer	0.0011	0.00399	CbGpPWpGaD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—SIRT1—brain cancer	0.0011	0.00397	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—brain cancer	0.00109	0.00393	CbGpPWpGaD
Bezafibrate—Constipation—Carmustine—brain cancer	0.00109	0.00444	CcSEcCtD
Bezafibrate—Pain—Carmustine—brain cancer	0.00109	0.00444	CcSEcCtD
Bezafibrate—Dyspepsia—Temozolomide—brain cancer	0.00108	0.00442	CcSEcCtD
Bezafibrate—Diarrhoea—Hydroxyurea—brain cancer	0.00108	0.0044	CcSEcCtD
Bezafibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.00108	0.00388	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—APC—brain cancer	0.00106	0.00383	CbGpPWpGaD
Bezafibrate—Pain—Temozolomide—brain cancer	0.00105	0.00429	CcSEcCtD
Bezafibrate—Constipation—Temozolomide—brain cancer	0.00105	0.00429	CcSEcCtD
Bezafibrate—CYP1A1—endocrine gland—brain cancer	0.00104	0.01	CbGeAlD
Bezafibrate—Dizziness—Hydroxyurea—brain cancer	0.00104	0.00425	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Carmustine—brain cancer	0.00104	0.00425	CcSEcCtD
Bezafibrate—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.00103	0.00372	CbGpPWpGaD
Bezafibrate—CYP1A1—head—brain cancer	0.00103	0.00988	CbGeAlD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00101	0.00365	CbGpPWpGaD
Bezafibrate—Abdominal pain—Carmustine—brain cancer	0.001	0.00411	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Temozolomide—brain cancer	0.001	0.00411	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—APC—brain cancer	0.000993	0.00359	CbGpPWpGaD
Bezafibrate—Rash—Hydroxyurea—brain cancer	0.000991	0.00405	CcSEcCtD
Bezafibrate—Dermatitis—Hydroxyurea—brain cancer	0.00099	0.00405	CcSEcCtD
Bezafibrate—PPARD—Adipogenesis—IRS2—brain cancer	0.000989	0.00357	CbGpPWpGaD
Bezafibrate—Headache—Hydroxyurea—brain cancer	0.000985	0.00403	CcSEcCtD
Bezafibrate—Infection—Etoposide—brain cancer	0.000976	0.00399	CcSEcCtD
Bezafibrate—Urticaria—Temozolomide—brain cancer	0.000976	0.00399	CcSEcCtD
Bezafibrate—Abdominal pain—Temozolomide—brain cancer	0.000971	0.00397	CcSEcCtD
Bezafibrate—Thrombocytopenia—Etoposide—brain cancer	0.000962	0.00393	CcSEcCtD
Bezafibrate—CYP1A1—central nervous system—brain cancer	0.000939	0.00901	CbGeAlD
Bezafibrate—Hypersensitivity—Carmustine—brain cancer	0.000936	0.00383	CcSEcCtD
Bezafibrate—Nausea—Hydroxyurea—brain cancer	0.000934	0.00382	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000925	0.00334	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000907	0.00328	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Temozolomide—brain cancer	0.000905	0.0037	CcSEcCtD
Bezafibrate—PPARA—Transmembrane transport of small molecules—S100A10—brain cancer	0.000884	0.00319	CbGpPWpGaD
Bezafibrate—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.00088	0.00318	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CDK4—brain cancer	0.000872	0.00315	CbGpPWpGaD
Bezafibrate—Diarrhoea—Carmustine—brain cancer	0.000869	0.00355	CcSEcCtD
Bezafibrate—Pruritus—Temozolomide—brain cancer	0.000869	0.00355	CcSEcCtD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000843	0.00304	CbGpPWpGaD
Bezafibrate—Dizziness—Carmustine—brain cancer	0.00084	0.00344	CcSEcCtD
Bezafibrate—Pain—Etoposide—brain cancer	0.00084	0.00344	CcSEcCtD
Bezafibrate—Constipation—Etoposide—brain cancer	0.00084	0.00344	CcSEcCtD
Bezafibrate—Diarrhoea—Temozolomide—brain cancer	0.00084	0.00344	CcSEcCtD
Bezafibrate—Dizziness—Temozolomide—brain cancer	0.000812	0.00332	CcSEcCtD
Bezafibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000811	0.00293	CbGpPWpGaD
Bezafibrate—CYP2C8—brain—brain cancer	0.000807	0.00775	CbGeAlD
Bezafibrate—Gastrointestinal pain—Etoposide—brain cancer	0.000803	0.00329	CcSEcCtD
Bezafibrate—Rash—Carmustine—brain cancer	0.000801	0.00328	CcSEcCtD
Bezafibrate—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000801	0.00289	CbGpPWpGaD
Bezafibrate—Dermatitis—Carmustine—brain cancer	0.0008	0.00327	CcSEcCtD
Bezafibrate—Headache—Carmustine—brain cancer	0.000796	0.00325	CcSEcCtD
Bezafibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	0.000791	0.00286	CbGpPWpGaD
Bezafibrate—Urticaria—Etoposide—brain cancer	0.000781	0.00319	CcSEcCtD
Bezafibrate—Abdominal pain—Etoposide—brain cancer	0.000777	0.00318	CcSEcCtD
Bezafibrate—Rash—Temozolomide—brain cancer	0.000774	0.00317	CcSEcCtD
Bezafibrate—Dermatitis—Temozolomide—brain cancer	0.000774	0.00316	CcSEcCtD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000771	0.00278	CbGpPWpGaD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.000771	0.00278	CbGpPWpGaD
Bezafibrate—Headache—Temozolomide—brain cancer	0.000769	0.00315	CcSEcCtD
Bezafibrate—CYP3A4—endocrine gland—brain cancer	0.000764	0.00734	CbGeAlD
Bezafibrate—Nausea—Carmustine—brain cancer	0.000755	0.00309	CcSEcCtD
Bezafibrate—PPARA—Adipogenesis—IRS2—brain cancer	0.000754	0.00272	CbGpPWpGaD
Bezafibrate—CYP1A1—brain—brain cancer	0.000745	0.00716	CbGeAlD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.00074	0.00267	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000732	0.00264	CbGpPWpGaD
Bezafibrate—Nausea—Temozolomide—brain cancer	0.000729	0.00298	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—CCND1—brain cancer	0.000728	0.00263	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Etoposide—brain cancer	0.000724	0.00296	CcSEcCtD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—brain cancer	0.000721	0.0026	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—CTNNB1—brain cancer	0.000721	0.0026	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.00071	0.00256	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.0007	0.00253	CbGpPWpGaD
Bezafibrate—Pruritus—Etoposide—brain cancer	0.000695	0.00284	CcSEcCtD
Bezafibrate—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000689	0.00249	CbGpPWpGaD
Bezafibrate—CYP3A4—central nervous system—brain cancer	0.000689	0.00661	CbGeAlD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000686	0.00248	CbGpPWpGaD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—CCND1—brain cancer	0.000681	0.00246	CbGpPWpGaD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—brain cancer	0.000675	0.00244	CbGpPWpGaD
Bezafibrate—Diarrhoea—Etoposide—brain cancer	0.000672	0.00275	CcSEcCtD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CDKN2A—brain cancer	0.000666	0.00241	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—SIRT1—brain cancer	0.00066	0.00238	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000658	0.00238	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000651	0.00235	CbGpPWpGaD
Bezafibrate—Dizziness—Etoposide—brain cancer	0.00065	0.00266	CcSEcCtD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000642	0.00232	CbGpPWpGaD
Bezafibrate—Rash—Etoposide—brain cancer	0.00062	0.00253	CcSEcCtD
Bezafibrate—Dermatitis—Etoposide—brain cancer	0.000619	0.00253	CcSEcCtD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000616	0.00223	CbGpPWpGaD
Bezafibrate—Headache—Etoposide—brain cancer	0.000616	0.00252	CcSEcCtD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—RELA—brain cancer	0.000612	0.00221	CbGpPWpGaD
Bezafibrate—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000611	0.00221	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—CTNNB1—brain cancer	0.000594	0.00214	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—brain cancer	0.000584	0.00211	CbGpPWpGaD
Bezafibrate—Nausea—Etoposide—brain cancer	0.000584	0.00239	CcSEcCtD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	0.000567	0.00205	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—CTNNB1—brain cancer	0.000566	0.00204	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000563	0.00204	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CCND1—brain cancer	0.000563	0.00203	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—ESR2—brain cancer	0.000556	0.00201	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000552	0.00199	CbGpPWpGaD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—MYC—brain cancer	0.000546	0.00197	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—TP53—brain cancer	0.000546	0.00197	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—IRS2—brain cancer	0.00054	0.00195	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—NOTCH2—brain cancer	0.000527	0.0019	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—STAT3—brain cancer	0.000517	0.00187	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000499	0.0018	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—CDK4—brain cancer	0.000499	0.0018	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TRPC6—brain cancer	0.000481	0.00174	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—brain cancer	0.000479	0.00173	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—SIRT1—brain cancer	0.000473	0.00171	CbGpPWpGaD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—STAT3—brain cancer	0.000464	0.00167	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—MYC—brain cancer	0.000458	0.00166	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—CTNNB1—brain cancer	0.000452	0.00163	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP2C9—brain cancer	0.00045	0.00163	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000443	0.0016	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000439	0.00158	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000435	0.00157	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—ESR2—brain cancer	0.000424	0.00153	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000422	0.00153	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000408	0.00148	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000404	0.00146	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—NOTCH2—brain cancer	0.000402	0.00145	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—STAT3—brain cancer	0.000394	0.00142	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000386	0.00139	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—BSG—brain cancer	0.000383	0.00138	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.00038	0.00137	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP2C9—brain cancer	0.000375	0.00136	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—CDK4—brain cancer	0.000358	0.00129	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000355	0.00128	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000349	0.00126	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000347	0.00126	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TRPC6—brain cancer	0.000345	0.00124	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000345	0.00124	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP2C9—brain cancer	0.000343	0.00124	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—IDH1—brain cancer	0.000329	0.00119	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—CTNNB1—brain cancer	0.000324	0.00117	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000323	0.00117	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—BSG—brain cancer	0.000319	0.00115	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000318	0.00115	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HES1—brain cancer	0.00031	0.00112	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ESR2—brain cancer	0.000304	0.0011	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—DNMT1—brain cancer	0.000298	0.00108	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000297	0.00107	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—BSG—brain cancer	0.000292	0.00105	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000292	0.00105	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000291	0.00105	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000291	0.00105	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—NOTCH2—brain cancer	0.000288	0.00104	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—STAT3—brain cancer	0.000282	0.00102	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—IDH1—brain cancer	0.000274	0.000991	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000273	0.000985	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000268	0.000969	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ESR2—brain cancer	0.000268	0.000968	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ENO2—brain cancer	0.00026	0.00094	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—NOTCH2—brain cancer	0.000254	0.000917	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—IDH1—brain cancer	0.000251	0.000906	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00025	0.000903	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP2C9—brain cancer	0.000246	0.000888	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CDK4—brain cancer	0.000243	0.000878	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00023	0.000832	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—DNMT1—brain cancer	0.000227	0.000821	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000223	0.000807	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HES1—brain cancer	0.000222	0.000802	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ENO2—brain cancer	0.000217	0.000783	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—SIRT1—brain cancer	0.000216	0.000779	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—brain cancer	0.000212	0.000767	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—BSG—brain cancer	0.000209	0.000755	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000204	0.000738	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ESR2—brain cancer	0.000204	0.000737	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000199	0.00072	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ENO2—brain cancer	0.000198	0.000716	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP2C9—brain cancer	0.000194	0.0007	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NOTCH2—brain cancer	0.000193	0.000698	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000183	0.00066	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—IDH1—brain cancer	0.00018	0.00065	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—RELA—brain cancer	0.000179	0.000646	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—ERBB2—brain cancer	0.000178	0.000642	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MYC—brain cancer	0.000176	0.000634	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CDK4—brain cancer	0.000174	0.000629	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—BSG—brain cancer	0.000165	0.000595	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—SIRT1—brain cancer	0.000164	0.000594	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—DNMT1—brain cancer	0.000163	0.000589	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CTNNB1—brain cancer	0.000155	0.000561	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—brain cancer	0.000152	0.000549	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000146	0.000529	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR2—brain cancer	0.000146	0.000528	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ENO2—brain cancer	0.000142	0.000513	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—IDH1—brain cancer	0.000142	0.000511	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH2—brain cancer	0.000139	0.0005	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—brain cancer	0.000137	0.000494	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—STAT3—brain cancer	0.000135	0.000489	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—brain cancer	0.000134	0.000483	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—RELA—brain cancer	0.000128	0.000463	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—ERBB2—brain cancer	0.000127	0.00046	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—brain cancer	0.000123	0.000445	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP2C9—brain cancer	0.000121	0.000438	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CG—brain cancer	0.000119	0.000431	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SIRT1—brain cancer	0.000118	0.000426	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000115	0.000416	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ENO2—brain cancer	0.000112	0.000404	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—brain cancer	0.000111	0.000402	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP2C9—brain cancer	0.000111	0.000402	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—BSG—brain cancer	0.000103	0.000373	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CG—brain cancer	9.95e-05	0.000359	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—brain cancer	9.81e-05	0.000354	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—brain cancer	9.71e-05	0.000351	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—brain cancer	9.59e-05	0.000346	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—BSG—brain cancer	9.46e-05	0.000342	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CG—brain cancer	9.1e-05	0.000329	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—IDH1—brain cancer	8.88e-05	0.000321	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—brain cancer	8.82e-05	0.000319	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—brain cancer	8.45e-05	0.000305	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—IDH1—brain cancer	8.14e-05	0.000294	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.23e-05	0.000261	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ENO2—brain cancer	7.02e-05	0.000253	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.63e-05	0.000239	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CG—brain cancer	6.52e-05	0.000236	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—brain cancer	6.44e-05	0.000233	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ENO2—brain cancer	6.43e-05	0.000232	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP2C9—brain cancer	5.97e-05	0.000216	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CG—brain cancer	5.14e-05	0.000185	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BSG—brain cancer	5.08e-05	0.000183	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—brain cancer	4.61e-05	0.000167	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—IDH1—brain cancer	4.37e-05	0.000158	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ENO2—brain cancer	3.45e-05	0.000125	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CG—brain cancer	3.22e-05	0.000116	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CG—brain cancer	2.95e-05	0.000107	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CG—brain cancer	1.58e-05	5.72e-05	CbGpPWpGaD
